Biblioteca Humberto Rosselli Quijano
The American Journal of Psychiatry
Mención de fecha: Enero
Fecha de aparición: 26/02/2025
|
Ejemplares (1)
|
| 102126 | The American Journal of Psychiatry | Publicaciones seriadas | Biblioteca Instituto Colombiano del Sistema Nervioso | Hemeroteca | Disponible |
Artículos
Añadir el resultado a su cesta
[artículo]
| Título : |
Psychedelics for the treatment of psychiatric disorders: interpreting and translating available evidence and guidance for future research |
| Tipo de documento: |
texto impreso |
| Autores: |
McIntyre, Roger S., Autor |
| Fecha de publicación: |
2025 |
| Artículo en la página: |
pp. 21–32 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Trastorno por consumo de alcohol, Trastornos depresivos, Metodología, Trastorno de estrés postraumático (TEPT), Psicodélicos, Trastornos adictivos y relacionados con sustancias. |
| Resumen: |
During the past decade, there has been extraordinary public, media, and medical research interest in psychedelics as promising therapeutics for difficult-to-treat psychiatric disorders. Short-term controlled trial data suggest that certain psychedelics are effective and safe in the treatment of major depressive disorder, treatment-resistant depression, and posttraumatic stress disorder. |
| Link: |
./index.php?lvl=notice_display&id=31556 |
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 21–32
[artículo] Psychedelics for the treatment of psychiatric disorders: interpreting and translating available evidence and guidance for future research [texto impreso] / McIntyre, Roger S., Autor . - 2025 . - pp. 21–32. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 21–32
| Palabras clave: |
Trastorno por consumo de alcohol, Trastornos depresivos, Metodología, Trastorno de estrés postraumático (TEPT), Psicodélicos, Trastornos adictivos y relacionados con sustancias. |
| Resumen: |
During the past decade, there has been extraordinary public, media, and medical research interest in psychedelics as promising therapeutics for difficult-to-treat psychiatric disorders. Short-term controlled trial data suggest that certain psychedelics are effective and safe in the treatment of major depressive disorder, treatment-resistant depression, and posttraumatic stress disorder. |
| Link: |
./index.php?lvl=notice_display&id=31556 |
|
[artículo]
| Título : |
Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression |
| Tipo de documento: |
texto impreso |
| Autores: |
Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor |
| Fecha de publicación: |
2025 |
| Artículo en la página: |
pp. 33-46 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
5-MeO-DMT, DMT, Depresión, Psicodélicos. |
| Resumen: |
Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention. |
| Link: |
./index.php?lvl=notice_display&id=31557 |
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46
[artículo] Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression [texto impreso] / Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor . - 2025 . - pp. 33-46. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46
| Palabras clave: |
5-MeO-DMT, DMT, Depresión, Psicodélicos. |
| Resumen: |
Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention. |
| Link: |
./index.php?lvl=notice_display&id=31557 |
|
[artículo]
| Título : |
Primum non nocere: the onus to characterize the potential harms of psychedelic treatment |
| Tipo de documento: |
texto impreso |
| Autores: |
Sharmin Ghaznavi, Autor ; Jeremy N. Ruskin, Autor ; Stephen J. Haggerty, Autor |
| Fecha de publicación: |
2025 |
| Artículo en la página: |
pp. 47-53 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Efectos adversos, Ética, Psicodélicos, Riesgos. |
| Resumen: |
The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. |
| Link: |
./index.php?lvl=notice_display&id=31558 |
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 47-53
[artículo] Primum non nocere: the onus to characterize the potential harms of psychedelic treatment [texto impreso] / Sharmin Ghaznavi, Autor ; Jeremy N. Ruskin, Autor ; Stephen J. Haggerty, Autor . - 2025 . - pp. 47-53. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 47-53
| Palabras clave: |
Efectos adversos, Ética, Psicodélicos, Riesgos. |
| Resumen: |
The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. |
| Link: |
./index.php?lvl=notice_display&id=31558 |
|
[artículo]
| Título : |
MDMA and MDMA- assisted therapy |
| Tipo de documento: |
texto impreso |
| Autores: |
Aaron S. Wolfgang, Autor ; Gregory A. Fonzo, Autor ; Joshua C. Gray, Autor |
| Fecha de publicación: |
2025 |
| Artículo en la página: |
pp. 79-103 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Estudios clínicos de medicamentos, Trastornos depresivos, MDMA, Trastorno depresivo mayor, Trastorno de estrés postraumático (TEPT). |
| Resumen: |
MDMA (i.e., 3,4-methylenedixoymethamphetamine), commonly known as “Ecstasy” or “Molly,” has been used since the 1970s both in recreational and therapeutic settings. The Food and Drug Administration (FDA) designated MDMA-Assisted Therapy (MDMA-AT) as a Breakthrough Therapy for posttraumatic stress disorder (PTSD) in 2017, and the FDA is requiring an additional phase 3 trial after rejecting the initial New Drug Application in 2024. |
| Link: |
./index.php?lvl=notice_display&id=31560 |
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 79-103
|
[artículo]
| Título : |
Multidimensional personality changes following psilocybin-assisted therapy in patients with alcohol use disorder: results from a double-blind, placebo-controlled clinical trial |
| Tipo de documento: |
texto impreso |
| Autores: |
Broc A. Pagni, Autor ; Richard J. Zeifman, Autor ; Sarah E. Mennenga, Autor |
| Fecha de publicación: |
2025 |
| Artículo en la página: |
pp. 114-125 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Dependencia del alcohol, Impulsividad, Personalidad, Terapia con psilocibina, Psicodélico. |
| Resumen: |
Evidence suggests that psilocybin-assisted therapy (PAT) leads to durable shifts in personality structure. However, such changes have yet to be characterized in disorders of addiction. In this secondary analysis from a randomized controlled trial, the authors examined the effect of PAT on personality dimensions in patients with alcohol use disorder (AUD), hypothesizing that PAT would attenuate personality abnormalities in AUD and that reductions in trait impulsiveness would be associated with lower drinking. |
| Link: |
./index.php?lvl=notice_display&id=31562 |
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 114-125
[artículo] Multidimensional personality changes following psilocybin-assisted therapy in patients with alcohol use disorder: results from a double-blind, placebo-controlled clinical trial [texto impreso] / Broc A. Pagni, Autor ; Richard J. Zeifman, Autor ; Sarah E. Mennenga, Autor . - 2025 . - pp. 114-125. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 114-125
| Palabras clave: |
Dependencia del alcohol, Impulsividad, Personalidad, Terapia con psilocibina, Psicodélico. |
| Resumen: |
Evidence suggests that psilocybin-assisted therapy (PAT) leads to durable shifts in personality structure. However, such changes have yet to be characterized in disorders of addiction. In this secondary analysis from a randomized controlled trial, the authors examined the effect of PAT on personality dimensions in patients with alcohol use disorder (AUD), hypothesizing that PAT would attenuate personality abnormalities in AUD and that reductions in trait impulsiveness would be associated with lower drinking. |
| Link: |
./index.php?lvl=notice_display&id=31562 |
|
